|Articles|July 28, 2017
World Hepatitis Day Tops SPT Week in Review
Author(s)Specialty Pharmacy Times Staff
Top articles of the week from Specialty Pharmacy Times.
Advertisement
5. HIV Suppression Maintained After Switch to Dolutegravir Regimen
Dolutegravir-based treatment non-inferior to boosted protease inhibitor regimen in virally suppressed HIV-positive patients.
4. The Role of Pharmacists in the Health Care Ecosystem
The future for pharmacy is very lucrative as they press on for provider status.
3. HER2-Positive Breast Cancer Market to Increase Substantially
Global market for HER2-positive breast cancer to increase to $9.89 billion in 2025.
2. Global Fight Against Hepatitis Continues with World Hepatitis Day
World Hepatitis Day brings awareness to the burden of hepatitis, which is a leading cause of death worldwide.
1. World Hepatitis Day: New WHO Data Reveal Why We Should Care, How Far We Have Come
Approximately 325 million individuals are living with hepatitis worldwide.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
2
Why Some Patients Do Not Respond to GLP-1 Therapies
3
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
4
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
5